NASDAQ NMS - GLOBAL MARKET · CYCN
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc

Biotechnology
$3.89
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
CYCN
Cyclerion Therapeutics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CYCN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CYCN catalysts
About Cyclerion Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
1
Country
US

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.89
Last session
Day high
$3.89
Last session
Day low
$3.89
Last session
Previous close
$3.89
52W high
$6.38
-39.03% from high
52W low
$1.08
53% of range
Market cap
$18.2M
EPS
$-1.5800
Beta
0.22
Shares out
4.7M
Avg volume
26K
VWAP
$3.89
Last session
Price history computed in-house
1W
-3.47%
1M
+11.14%
3M
+21.56%
1Y
+56.22%
YTD
+206.30%
SMA 50 $3.56 · above
SMA 200 $2.42 · above
52W position 53%

CYCN overview

Veridion Score
65
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CYCN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CYCN Form 4 filings
Public disclosures

Congress activity in CYCN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CYCN in the cached public ledger.

Federal contracts

CYCN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CYCN in this window.
Lobbying spend

CYCN lobbying filings, year to date.

Registered lobbying filings matched to Cyclerion Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CYCN in this window.
Loading news for CYCN
Analyst ratings
Sovereign unlock shows live analyst consensus for CYCN.
Options
Sovereign unlock shows live options positioning for CYCN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.